Enhancer variants on chromosome 2p14 regulating SPRED2 and ACTR2 act as a signal amplifier to protect against rheumatoid arthritis.

Genome-wide association studies (GWASs) have repeatedly reported multiple non-coding single-nucleotide polymorphisms (SNPs) at 2p14 associated with rheumatoid arthritis (RA), but their functional roles in the pathological mechanisms of RA remain to be explored. In this study, we integrated a series of bioinformatics and functional experiments and identified three intronic RA SNPs (rs1876518, rs268131, and rs2576923) within active enhancers that can regulate the expression of SPRED2 directly. At the same time, SPRED2 and ACTR2 influence each other as a positive feedback signal amplifier to strengthen the protective role in RA by inhibiting the migration and invasion of rheumatoid fibroblast-like synoviocytes (FLSs). In particular, the transcription factor CEBPB preferentially binds to the rs1876518-T allele to increase the expression of SPRED2 in FLSs. Our findings decipher the molecular mechanisms behind the GWAS signals at 2p14 for RA and emphasize SPRED2 as a potential candidate gene for RA, providing a potential target and direction for precise treatment of RA. Copyright © 2023 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Citation

Nai-Ning Wang, Yan Zhang, Feng Jiang, Dong-Li Zhu, Chen-Xi Di, Shou-Ye Hu, Xiao-Feng Chen, Li-Qiang Zhi, Yu Rong, Xin Ke, Yuan-Yuan Duan, Shan-Shan Dong, Tie-Lin Yang, Zhi Yang, Yan Guo. Enhancer variants on chromosome 2p14 regulating SPRED2 and ACTR2 act as a signal amplifier to protect against rheumatoid arthritis. American journal of human genetics. 2023 Apr 06;110(4):625-637

Mesh Tags

Substances

PMID: 36924774

search → result